Lv7
4640 积分 2023-10-08 加入
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide
2小时前
已完结
Genomics of drug target prioritization for complex diseases
12天前
已完结
PCSK9 Inhibitors in Diabetes, Tirzepatide’s Cardiorenal Effects, Shingles Vaccine, and More From ACC
17天前
已完结
Lipid Lowering in 2026
17天前
已完结
Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes
17天前
已完结
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide
1个月前
已完结
Efficacy and Safety of Oral PCSK9 Inhibitor Enlicitide in Adults With Heterozygous Familial Hypercholesterolemia
1个月前
已完结
Oral PCSK9 Inhibitor Enlicitide versus Oral Non-statin Therapies: A Phase 3 Randomized Clinical Trial
1个月前
已关闭
Evolocumab in Patients without a Previous Myocardial Infarction or Stroke
1个月前
已完结
Efficacy of Tonlamarsen in Patients with Uncontrolled Hypertension: The KARDINAL Phase 2 Randomized Clinical Trial
1个月前
已完结
皖公网安备34019202002308
